Search
for
Sort by
Research 31–60 of 217
- ‘Relaxers’ damage hair: Evidence from amino acid analysis
- Congenital adrenal hyperplasia
- Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Nonclassic Congenital Adrenal Hyperplasia
- The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Skin steroidogenesis in health and disease
- Nonclassic congenital adrenal hyperplasia
- Vitamin D metabolism and function in the skin
- Extraskeletal actions of vitamin D
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Association of Cyp11a Gene with Polycystic Ovarian Syndrome Patients in Lahore, Pakistan
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Polycystic ovary syndrome and impact on health
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Role of skin enzymes in metabolism of topical drugs
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Study on Changes of 19 Steroids in Plasma From 9 Diagnosed Patients With P450 Oxidoreductase Deficiency
- Definition criteria and diagnostic assessments